Hricak Hedvig, Gatsonis Constantine, Coakley Fergus V, Snyder Bradley, Reinhold Caroline, Schwartz Lawrence H, Woodward Paula J, Pannu Harpreet K, Amendola Marco, Mitchell Donald G
Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Radiology. 2007 Nov;245(2):491-8. doi: 10.1148/radiol.2452061983.
To retrospectively compare diagnostic performance and interobserver variability for computed tomography (CT) and magnetic resonance (MR) imaging in the pretreatment evaluation of early invasive cervical cancer, with surgical pathologic findings as the reference standard.
This HIPAA-compliant study had institutional review board approval and informed consent for evaluation of preoperative CT (n = 146) and/or MR imaging (n = 152) studies in 156 women (median age, 43 years; range, 22-81 years) from a previous prospective multicenter American College of Radiology Imaging Network and Gynecologic Oncology Group study of 172 women with biopsy-proved cervical cancer (clinical stage > or = IB). Four radiologists (experience, 7-15 years) interpreted the CT scans, and four radiologists (experience, 12-20 years) interpreted the MR studies retrospectively. Tumor visualization and detection of parametrial invasion were assessed with receiver operating characteristic curves (with P < or = .05 considered to indicate a significant difference). Descriptive statistics for staging and kappa statistics for reader agreement were calculated. Surgical pathologic findings were the reference standard.
For CT and MR imaging, respectively, multirater kappa values were 0.26 and 0.44 for staging, 0.16 and 0.32 for tumor visualization, and -0.04 and 0.11 for detection of parametrial invasion; for advanced stage cancer (> or =IIB), sensitivities were 0.14-0.38 and 0.40-0.57, positive predictive values (PPVs) were 0.38-1.00 and 0.32-0.39, specificities were 0.84-1.00 and 0.77-0.80, and negative predictive values (NPVs) were 0.81-0.84 and 0.83-0.87. MR imaging was significantly better than CT for tumor visualization (P < .001) and detection of parametrial invasion (P = .047).
Reader agreement was higher for MR imaging than for CT but was low for both. MR imaging was significantly better than CT for tumor visualization and detection of parametrial invasion. The modalities were similar for staging, sharing low sensitivity and PPV but relatively high NPV and specificity.
以手术病理结果为参考标准,回顾性比较计算机断层扫描(CT)和磁共振成像(MR)在早期浸润性宫颈癌术前评估中的诊断性能及观察者间的变异性。
本符合健康保险流通与责任法案(HIPAA)的研究获得了机构审查委员会的批准,并取得了知情同意,用于评估156名女性(年龄中位数为43岁;范围为22 - 81岁)之前的术前CT(n = 146)和/或MR成像(n = 152)研究,这些研究来自美国放射学会影像网络和妇科肿瘤学组之前一项针对172名经活检证实为宫颈癌(临床分期≥IB期)的前瞻性多中心研究。四名放射科医生(经验为7 - 15年)解读CT扫描图像,四名放射科医生(经验为12 - 20年)回顾性解读MR研究图像。采用受试者操作特征曲线评估肿瘤可视化及宫旁浸润的检测情况(P≤0.05被认为具有显著差异)。计算分期的描述性统计量及读者一致性的kappa统计量。手术病理结果为参考标准。
对于CT和MR成像,分期的多评估者kappa值分别为0.26和0.44,肿瘤可视化的kappa值分别为0.16和0.32,宫旁浸润检测的kappa值分别为 - 0.04和0.11;对于晚期癌症(≥IIB期),敏感性分别为0.14 - 0.38和0.40 - 0.57,阳性预测值(PPV)分别为0.38 - 1.00和0.32 - 0.39,特异性分别为0.84 - 1.00和0.77 - 0.80,阴性预测值(NPV)分别为0.81 - 0.84和0.83 - 0.87。MR成像在肿瘤可视化(P < 0.001)和宫旁浸润检测(P = 0.047)方面显著优于CT。
MR成像的读者一致性高于CT,但两者均较低。MR成像在肿瘤可视化和宫旁浸润检测方面显著优于CT。两种检查方式在分期方面相似,敏感性和PPV较低,但NPV和特异性相对较高。